Compounder sues Lilly and Novo for suppressing GLP-1RA competition [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Strive Compounding Pharmacy said that the drugmakers, who dominate the glucagon-like peptide-1 receptor agonist (GLP-1RA) market, are engaging in a “coordinated effort to suppress competition and limit patient access to lawful compounded GLP-1RA medications”. The lawsuit, filed in the United States District Court for the Western District of Texas, alleges that Lilly and Novo used their dominant market positions to undermine the compounding pharmacy industry. The document highlights exclusive partnerships that the pharma companies signed with telehealth providers in efforts to compete with the compounding sector. It also points to Lilly and Novo establishing their own online pharmacies in the past year, which offer branded GLP-1RAs via direct-to-consumer (DTC) cash channels at a discounted price. Through these alliances, online DTC platforms, and apparent marketing strategies, Strive alleges that Lilly and Novo's conduct “unlawfully restricted competition and directly harmed GLP-1
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk (NYSE:NVO) Valuation Check After Sharp 1 Month Rebound And Mixed Long Term Returns [Yahoo! Finance]Yahoo! Finance
- Airlines have 580 million reasons to like GLP-1 weight-loss drugs, analysis finds [Yahoo! Finance]Yahoo! Finance
- Drugmakers hike medicine prices in 2026. How much more will you spend? [USA TODAY]USA TODAY
- How Eli Lilly's leader won Trump's favor [Yahoo! Finance]Yahoo! Finance
- Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website